相关实验视频
Updated: Jul 25, 2025

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
RYR2 - 氨基酸病变:从过载到缺乏症
Christian Steinberg1, Thomas M Roston2, Christian van der Werf3
1Institut universitaire de cardiologie et pneumologie de Québec, Laval University, 2725, Chemin Ste-Foy, Quebec G1V 4G5, Canada.
心脏瑞诺丁受体RyR2中的突变会导致遗传性心律失常症,如CPVT和CRDS. 了解这些独特的RYR2-ryanodinopathies对于有效的临床管理至关重要.
科学领域:
- 心血管遗传学 心血管遗传学
- 分子心脏病学分子心脏病学
- 电子生理学 电子生理学
背景情况:
- 心脏里亚诺丁受体RyR2调节心脏功能所必需的释放.
- RYR2突变会导致遗传性心律失常症,包括catecholaminergic多形心室性心跳动 (CPVT).
- 已出现明显的RYR2相关疾病,如RYR2外因子-3删除综合征和释缺陷综合征 (CRDS).
研究的目的:
- 为提供与RYR2相关的遗传性心律失常障碍的全面审查.
- 系统地描述不同的心脏类病变,包括CPVT,RYR2外因子-3删除综合征和CRDS.
- 讨论这些复杂的心脏遗传性疾病的临床方面和分子洞察力.
主要方法:
- 对与RYR2相关的遗传性心律失常障碍的文献综述.
- 临床表现和分子机制的系统分析.
- 综合当前关于心脏氨酸病的知识.
主要成果:
- 心脏 Ryanodinopathies 由复杂的机制导致异常的SR释放.
- CPVT通常与RyR2功能增益变体有关.
- CRDS与RyR2功能丧失变体相关,在机制上与CPVT不同.
结论:
- 准确识别特定的心脏 Ryanodinopathies 对于患者管理至关重要.
- 越来越多的RYR2相关疾病突显了它们的复杂性和临床挑战.
- 本综述为临床医生提供了对RYR2相关遗传性心律失常的当代理解.
更多相关视频
11:31Crystal Structure of the N-terminal Domain of Ryanodine Receptor from Plutella xylostella
Published on: November 30, 2018
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Cardiomyopathy I: Introduction and Classification
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Rheumatic Heart Disease I: Introduction